We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Genzyme Therapeutics

4620 Kingsgate, Cascade Way, Oxford Business Park South, Oxford, Oxfordshire, OX4 2SU
Telephone: +44 (0)1865 405 200
Fax: +44 (0)1865 774 172
WWW: http://www.genzyme.co.uk
Medical Information Direct Line: +44 (0)1865 405 283
Medical Information e-mail: ukmedinfo@genzyme.com
Customer Care direct line: +44 (0)1865 405 200
Medical Information Facsimile: +44 (0)1865 774 172
Patient Information Leaflet last updated on medicines.ie: 2/12/2018
PIL Caprelsa 100mg and 300mg film coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 2/12/2018 and displayed until Current
Reasons for adding or updating:
  • Improved presentation of PIL
Updated on 12/22/2016 and displayed until 2/12/2018
Reasons for adding or updating:
  • Change to section 1 - what the product is used for
  • Change to section 2 - use in children and adolescents
  • Change to section 3 - use in children/adolescents
  • Change to section 6 - manufacturer
Updated on 9/22/2016 and displayed until 12/22/2016
Reasons for adding or updating:
  • Change to further information section
  • Change to marketing authorisation holder
Updated on 2/3/2016 and displayed until 9/22/2016
Reasons for adding or updating:
  • Change to date of revision
  • Correction of spelling/typing errors
Updated on 5/8/2015 and displayed until 2/3/2016
Reasons for adding or updating:
  • Change to date of revision
  • Addition of information on reporting a side effect.
Updated on 10/31/2014 and displayed until 5/8/2015
Reasons for adding or updating:
  • Addition of information on reporting a side effect.
Updated on 7/1/2014 and displayed until 10/31/2014
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Vandetanib